UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GlobSed: Updated Total Sediment Thickness in the World's Oceans

Geochemistry, geophysics, geosystems : G3, 2019-04, Vol.20 (4), p.1756-1772

2019

Volltextzugriff (PDF)

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Annals of oncology, 2019-07, Vol.30 (7), p.1154-1161

2019

Volltextzugriff (PDF)

Perioperative factors and complications after delayed reconstruction in breast cancer patients in relation to outcome

Annals of oncology, 2019-05, Vol.30, p.iii41-iii41

2019

Volltextzugriff (PDF)

Update on the randomised phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma

Annals of oncology, 2018-10, Vol.29, p.viii452-viii452

2018

Volltextzugriff (PDF)

Climate transition at the Eocene-Oligocene influenced by bathymetric changes to the Atlantic-Arctic oceanic gateways

Proceedings of the National Academy of Sciences - PNAS, 2022-04, Vol.119 (17), p.e2115346119

2022

Volltextzugriff (PDF)

Perspectives on Gas Hydrates Cold Flow Technology

Energy & fuels, 2019-01, Vol.33 (1), p.1-15

2019

Volltextzugriff (PDF)

A bench-scale flow loop study on hydrate deposition under multiphase flow conditions

Fuel (Guildford), 2020-02, Vol.262, p.116558, Article 116558

2020

Volltextzugriff (PDF)

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

ESMO open, 2022-10, Vol.7 (5), p.100588-100588, Article 100588

2022

Volltextzugriff (PDF)

Experimental study of the formation and deposition of gas hydrates in non-emulsifying oil and condensate systems

Chemical engineering science, 2016-11, Vol.155, p.111-126

2016

Volltextzugriff (PDF)

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1 EPHA2, and reduced thrombospondin-1 in malignant melanoma

British journal of cancer, 2005-10, Vol.93 (8), p.933-938

2005

Volltextzugriff (PDF)

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

British journal of cancer, 2011-06, Vol.105 (1), p.9-12

2011

Volltextzugriff (PDF)

Gas Hydrate Sloughing as Observed and Quantified from Multiphase Flow Conditions

Energy & fuels, 2018-03, Vol.32 (3), p.3399-3405

2018

Volltextzugriff (PDF)

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

The New England journal of medicine, 2017-11, Vol.377 (19), p.1824-1835

2017

Volltextzugriff (PDF)

A randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma

Annals of oncology, 2019-10, Vol.30, p.v563

2019

Volltextzugriff (PDF)

1336TiP - A randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma

Annals of oncology, 2019-10, Vol.30, p.v563-v563

2019

Volltextzugriff (PDF)

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2015-11, Vol.373 (19), p.1803-1813

2015

Volltextzugriff (PDF)

Downstream merger with upstream market power

European economic review, 2005-04, Vol.49 (3), p.717-743

2005

Volltextzugriff (PDF)

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

Journal of clinical oncology, 2006-01, Vol.24 (2), p.268-273

2006

Volltextzugriff (PDF)

Quality competition with profit constraints

Journal of economic behavior & organization, 2012-11, Vol.84 (2), p.642-659

2012

Volltextzugriff (PDF)

LBA52 A randomized phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma

Annals of oncology, 2023-10, Vol.34, p.S1291-S1291

2023

Volltextzugriff (PDF)

Global Cenozoic Paleobathymetry with a focus on the Northern Hemisphere Oceanic Gateways

Gondwana research, 2020-10, Vol.86, p.126-143

2020

Volltextzugriff (PDF)

1336TiPA randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype

JNCI : Journal of the National Cancer Institute, 2006-03, Vol.98 (5), p.316-325

2006

Volltextzugriff (PDF)

129PPerioperative factors and complications after delayed reconstruction in breast cancer patients in relation to outcome

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

Impact of mantle convection and dynamic topography on the Cenozoic paleogeography of Central Eurasia and the West Siberian Seaway

Earth and planetary science letters, 2024-03, Vol.630, p.118615, Article 118615

2024

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Englisch
(149)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

GlobSed: Updated Total Sediment Thickness in the World's Oceans

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Perioperative factors and complications after delayed reconstruction in breast cancer patients in relation to outcome

Update on the randomised phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma

Climate transition at the Eocene-Oligocene influenced by bathymetric changes to the Atlantic-Arctic oceanic gateways

Perspectives on Gas Hydrates Cold Flow Technology

A bench-scale flow loop study on hydrate deposition under multiphase flow conditions

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

Experimental study of the formation and deposition of gas hydrates in non-emulsifying oil and condensate systems

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1 EPHA2, and reduced thrombospondin-1 in malignant melanoma

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

Gas Hydrate Sloughing as Observed and Quantified from Multiphase Flow Conditions

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

A randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma

1336TiP - A randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Downstream merger with upstream market power

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

Quality competition with profit constraints

LBA52 A randomized phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma

Global Cenozoic Paleobathymetry with a focus on the Northern Hemisphere Oceanic Gateways

1336TiPA randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma

A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype

129PPerioperative factors and complications after delayed reconstruction in breast cancer patients in relation to outcome

Impact of mantle convection and dynamic topography on the Cenozoic paleogeography of Central Eurasia and the West Siberian Seaway

Aktive Filter

Suchergebnisse filtern